Multi-omic and multimodal datasets with detailed clinical annotations offer significant potential to advance our understanding of inflammatory bowel diseases (IBD), refine diagnostics, and enable personalized therapeutic strategies. In this multi-cohort study, we performed an extensive multi-omic and multimodal analysis of 1,002 clinically annotated patients with IBD and non-IBD controls, incorporating whole-exome and RNA sequencing of normal and inflamed gut tissues, serum proteomics, and histopathological assessments from images of H&E-stained tissue sections. Transcriptomic profiles of normal and inflamed tissues revealed distinct site-specific inflammatory signatures in Crohn's disease (CD) and ulcerative colitis (UC). Leveraging serum proteomics, we developed an inflammatory protein severity signature that reflects underlying intestinal molecular inflammation. Furthermore, foundation model-based deep learning accurately predicted histologic disease activity scores from images of H&E-stained intestinal tissue sections, offering a robust tool for clinical evaluation. Our integrative analysis highlights the potential of combining multi-omics and advanced computational approaches to improve our understanding and management of IBD.
IBDome: An integrated molecular, histopathological, and clinical atlas of inflammatory bowel diseases.
阅读:3
作者:Plattner Christina, Sturm Gregor, Kühl Anja A, Atreya Raja, Carollo Sandro, Gronauer Raphael, Rieder Dietmar, Günther Michael, Ormanns Steffen, Manzl Claudia, Wirtz Stefan, Meneghetti Asier Rabasco, Hegazy Ahmed N, Patankar Jay V, Carrero Zunamys I, Neurath Markus F, Kather Jakob Nikolas, Becker Christoph, Siegmund Britta, Trajanoski Zlatko
| 期刊: | bioRxiv | 影响因子: | 0.000 |
| 时间: | 2025 | 起止号: | 2025 Apr 10 |
| doi: | 10.1101/2025.03.26.645544 | ||
特别声明
1、本文转载旨在传播信息,不代表本网站观点,亦不对其内容的真实性承担责任。
2、其他媒体、网站或个人若从本网站转载使用,必须保留本网站注明的“来源”,并自行承担包括版权在内的相关法律责任。
3、如作者不希望本文被转载,或需洽谈转载稿费等事宜,请及时与本网站联系。
4、此外,如需投稿,也可通过邮箱info@biocloudy.com与我们取得联系。
